Arcellx, Inc.

NASDAQ:ACLX

76.79 (USD) • At close December 23, 2024
Bedrijfsnaam Arcellx, Inc.
Symbool ACLX
Munteenheid USD
Prijs 76.79
Beurswaarde 4,152,393,909
Dividendpercentage 0%
52-weken bereik 47.88 - 107.37
Industrie Biotechnology
Sector Healthcare
CEO Mr. Rami Elghandour
Website https://arcellx.com

An error occurred while fetching data.

Over Arcellx, Inc.

Arcellx, Inc., a clinical-stage biotechnology company, engages in the development of various immunotherapies for patients with cancer and other incurable diseases. The company's lead ddCAR product candidate is CART-ddBCMA, which is in phase 1 clinical trial for the treatment of patients with relapsed or refractory (r/r) multiple myeloma (MM). It

Vergelijkbare Aandelen

Kodiak Sciences Inc. logo

Kodiak Sciences Inc.

KOD

9.25 USD

Regencell Bioscience Holdings Limited logo

Regencell Bioscience Holdings Limited

RGC

4.77 USD

Belite Bio, Inc logo

Belite Bio, Inc

BLTE

62.82 USD

Outlook Therapeutics, Inc. logo

Outlook Therapeutics, Inc.

OTLK

1.42 USD

Esperion Therapeutics, Inc. logo

Esperion Therapeutics, Inc.

ESPR

2.24 USD

Arbutus Biopharma Corporation logo

Arbutus Biopharma Corporation

ABUS

3.19 USD

Tyra Biosciences, Inc. logo

Tyra Biosciences, Inc.

TYRA

14.25 USD

Mind Medicine (MindMed) Inc. logo

Mind Medicine (MindMed) Inc.

MNMD

7.08 USD

Financiële Gegevens

Cijfers zijn in miljoenen (USD)

Cijfers zijn in miljoenen (USD)